Disclosures for "A Quantitative Approach to Telemedicine Assessment of Ptosis and Ocular Motility for Patients with Myasthenia Gravis")
-
Mr. Lesport has nothing to disclose.
-
Dr. Joerger has nothing to disclose.
-
The institution of Dr. Kaminski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Kaminski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Kaminski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cabaletta Bio. Dr. Kaminski has stock in ARC Biotechnology. The institution of Dr. Kaminski has received research support from National Institutes of Health. Dr. Kaminski has received publishing royalties from a publication relating to health care.
-
Helen Girma has nothing to disclose.
-
Ms. McNett has nothing to disclose.
-
Dr. Abu-Rub has nothing to disclose.
-
Prof. Garbey has stock in Care Constitution, LLC. Prof. Garbey has a non-compensated relationship as a CEO with Care Constitution, LLC that is relevant to AAN interests or activities.